OSTX · OS Therapies Inc
$1.71
+0.05 (+3.01%)
At close · Sep 2
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$76.57M
Shares
46.13M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-08-25 | New | Biotechnology | $10,000,000 | $5,000,000 | 06b |
| 2026-07-16 | New | Biotechnology | $9,250,000 | $1,600,000 | 06b |
| 2026-03-06 | New | Biotechnology | $2,000,000 | $2,000,000 | 06b |
| 2026-01-20 | New | Biotechnology | $7,531,884 | $3,498,650 | 06b |
| 2025-09-10 | New | Biotechnology | $3,777,808 | $3,777,808 | 06b |
| 2025-07-16 | New | Biotechnology | $4,216,794 | $4,216,794 | 06b |
| 2025-01-22 | New | Pharmaceuticals | $10,000,000 | $7,103,000 | 06b |
| 2023-12-14 | New | Biotechnology | $2,000,000 | $700,000 | 06b |
| 2023-01-11 | New | Other Health Care | $2,000,000 | $2,000,000 | 06b |
| 2021-09-01 | New | Other Health Care | $5,000,000 | $1,000,000 | 06b |
| 2020-05-01 | New | Other Health Care | $5,000,000 | $0 | 06b |
Showing 1–11 of 11 filings
Key facts
CIK
1795091
CUSIP
68764Y207
13F (30d)
27 filings
27 filers
Visit website
Investor relations